Formulation: A solution in chloroform
Purity: ≥98%
Oleoyl 3-
Inhibitor of autotaxin, antagonist of LPA1 and LPA3
CAS No. 779333-58-3
Item No. 10010299
Formulation: A 10 mg/ml solution in chloroform
Purity: ≥95%
- 3-
ccPA 18:1
Formulation: A crystalline solid
Purity: ≥95%
- 3-
ccPA 16:0
Palmitoleoyl 3-carbacyclic Phosphatidic Acid
Inhibitor of autotaxin
CAS No. 910228-13-6
Item No. 10010298
Formulation: A 10 mg/ml solution in chloroform
Purity: ≥95%
- 3-carbacyclic PA
- 3-ccPA 16:1
Formulation: A solid
Purity: ≥95%
- 1,2-Dioctadecenoyl-sn-glycero-3-PA
- 1,2-Dioctadecenoyl-sn-glycero-3-phosphatidic Acid
- 1,2-Dioleoyl-sn-glycero-3-phosphate
- 1,2-Dioleoyl-sn-glycero-3-phosphatidic Acid
- 1,2-DOPA
- 18:1/18:1-PA
Formulation: A crystalline solid
Purity: ≥95%
- 1,2-Dilauroyl-sn-glycero-3-phosphate
- 1,2-Dilauroyl-sn-glycero-3-phosphatidic Acid
- 1,2-DLPA
Formulation: A crystalline solid
Purity: ≥98%
- BL 194
- CT-
1501R - LSF
Formulation: A 5 mg/ml solution in chloroform
Purity: ≥95%
- 1,2-Dioctadecenoyl-sn-glycero-3-PA
- 1,2-Dioctadecenoyl-sn-glycero-3-phosphatidic Acid
- 1,2-Dioleoyl-sn-glycero-3-phosphate
- 1,2-Dioleoyl-sn-glycero-3-phosphatidic Acid
- 1,2-DOPA
- 18:1/18:1-PA
- PA(18:1/18:1)
Formulation: A crystalline solid
Purity: ≥98%
- 1,2-Dipalmitoyl-sn-glycero-3-phosphatidic Acid
- 1,2-Dipalmitoyl-sn-glycero-3-phosphate
- 1,2-DPPA
- 16:0/16:0-PA
Formulation: A crystalline solid
Purity: ≥98%
- 1,2-Dimyristoyl-sn-glycero-3-phosphate
- 1,2-Dimyristoyl-sn-glycero-3-phosphatidic Acid
- 1,2-DPPA
- 14:0/14:0-PA
- PA(14:0/14:0)
1,2-
A negatively charged phospholipid
CAS No. 108321-18-2
Item No. 15083
Formulation: A crystalline solid
Purity: ≥98%
- 1,2-Distearoyl-sn-glycero-3-phosphate
- 1,2-Distearoyl-sn-glycero-3-phosphatidic Acid
- 1,2-DSPA
- 18:0/18:0-PA
- PA (18:0/18:0)
Formulation: A 5 mg/ml solution in chloroform
Purity: ≥95%
- 16:0-18:1 PA
- 16:0/18:1-PA
- PA(16:0/18:1)
- 1-Hexadecanoyl-2-Octadecenoyl-sn-glycero-3-PA
- 1-Hexadecanoyl-2-Octadecenoyl-sn-glycero-3-phosphate
- 1-Hexadecanoyl-2-Octadecanoyl-sn-glycero-3-phosphatidic Acid
- 1-Palmitoyl-2-Oleoyl-sn-glycero-3-phosphate
- 1-Palmitoyl-2-Oleoyl-sn-glycero-3-Phosphatidic Acid
- 1,2-POPA
Formulation: A crystalline solid
Purity: ≥97%
- (−)-Lisofylline
- (R)-
LSF
(S)-
The inactive enantiomer of a potent anti-
CAS No. 100324-80-9
Item No. 13617
Formulation: A crystalline solid
Purity: ≥98%
- (+)-
Lisofylline - (S)-
LSF
MBOAT2 (Internal) Polyclonal Antibody
For immunochemical detection of the internal portion of MBOAT2
Item No. 15647
Immunogen: Human MBOAT2, internal region (cytoplasmic)
Host: Rabbit
Applications: FC, IF
1-Oleoyl-2-hydroxy-sn-glycero-3-PA (sodium salt)
A potent LPA receptor agonist
CAS No. 325465-93-8
Item No. 62215
Formulation: A crystalline solid
Purity: ≥95%
- PA(18:1/0:0)
- 18:1 LPA
- LPA 18:1
- 1-Octadecenoyl-2-hydroxy-sn-glycero-3-phosphate
- 1-Oleoyl LPA
- 1-Oleoyl Lysophosphatidic Acid
Immunogen: Synthetic peptide from the C-terminal cytoplasmic region of human protein LPA1
Host: Rabbit
Applications: ICC, IF, IHC, and WB
Formulation: A 10 mg/ml solution in ethanol
Purity: ≥95%
- 18:1 LPA
- LPA 18:1
- 1-Octadecenoyl-2-hydroxy-sn-glycero-3-phosphate
- 1-Oleoyl LPA
- 1-Oleoyl Lysophosphatidic Acid
- PA(18:1/0:0)
1-Palmityl-2-hydroxy-sn-glycero-3-PA
An ether analog of lysophosphatidic acid
CAS No. 52603-03-9
Item No. 10010188
Formulation: A crystalline solid
Purity: ≥98%
- 1-Hexadecyl-2-hydroxy-sn-glycero-3-phosphate
- 1-Hexadecyl LPA
- 1-Hexadecyl Lysophosphatidic Acid
- LPA O-16:0
- O-16:0 LPA
- PA(O-16:0/0:0)
- 1-Palmityl LPA
- 1-Palmityl Lysophosphatidic Acid
Immunogen: Synthetic peptide from the N-terminal region of mouse protein LPA3
Host: Rabbit
Applications: ICC, IF, and WB
1-Octadecyl-2-
A lysophosphatidic acid analog
CAS No. 52977-29-4
Item No. 10010164
Formulation: A crystalline solid
Purity: ≥95%
- LPA O-18:0
- O-18:0 LPA
- 1-Octadecyl-2-hydroxy-sn-glycero-3-PA
- 1-Octadecyl LPA
- 1-Octadecyl Lysophosphatidic Acid
- 1-Oleyl LPA
- 1-Oleyl Lysophosphatidic Acid
- PA(O-18:0/0:0)
- 1-Stearyl-2-hydroxy-sn-glycero-3-PA
1-Octadecyl-2-hydroxy-sn-glycero-3-phosphate (sodium salt)
A lysophosphatidic acid analog
Item No. 10010291
Formulation: A crystalline solid
Purity: ≥95%
- LPA O-18:0
- O-18:0 LPA
- 1-Octadecyl-2-hydroxy-sn-glycero-3-PA
- 1-Octadecyl LPA
- 1-Octadecyl Lysophosphatidic Acid
- 1-Oleyl LPA
- 1-Oleyl Lysophosphatidic Acid
- PA(O-18:0/0:0)
- 1-Stearyl-2-hydroxy-sn-glycero-3-PA
Formulation: A crystalline solid
Purity: ≥98%
- 1-Hexadecyl-2-hydroxy-sn-glycero-3-phosphate
- 1-Hexadecyl LPA
- 1-Hexadecyl Lysophosphatidic Acid
- LPA O-16:0
- O-16:0 LPA
- PA(O-16:0/0:0)
- 1-Palmityl LPA
- 1-Palmityl Lysophosphatidic Acid
Phosphatidyl
Assay for the quantification of phosphatidylcholine in plasma or serum
Item No. 10009926
- PC
1-Palmitoyl-2-hydroxy-sn-glycero-3-PA
A lysophosphatidic acid analog
CAS No. 7220-34-0
Item No. 10010094
Formulation: A crystalline solid
Purity: ≥95%
- 1-Hexadecanoyl-2-hydroxy-sn-glycero-3-phosphate
- 16:0 LPA
- LPA 16:0
- PA(16:0/0:0)
- 1-Palmitoyl LPA
- 1-Palmitoyl Lysophosphatidic Acid
Contact Info
Cayman Chemical1180 East Ellsworth RoadAnn Arbor, Michigan 48108 USAToll Free: (800) 364-9897(USA and Canada only)Fax: (734) 971-3640
